AntriaBio raises $3.4M of possible $25M common-stock offering

LOUISVILLE — AntriaBio Inc. (OTC: ANTB) has raised $3.36 million of a planned offering of common stock, options and warrants that when completed could raise up to $25.4 million for the Louisville-based pharmaceutical company.

According to a Regulation D filing with the Securities and Exchange Commission submitted earlier this week, 190 investors have taken part in the offering that began Jan. 31. The filing said $22.1 million remains to be raised.

AntriaBio, led by co-founder, chairman and chief executive Nevan Charles Elam, develops extended-release therapies to treat diseases that have a need for longer-acting drugs.